Curevac N.V. (NQ: CVAC )
2.800
-0.020
(-0.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
All News about Curevac N.V.![]() ![]()
CureVac to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Technology
October 12, 2021
From CureVac
Via AccessWire
![]() ![]() ![]() ![]() Via Benzinga
![]() ![]()
Scientists Rapidly Advancing Cancer Vaccine Prospects Using Same Technology as Covid-19 Shots
September 17, 2021
Exposures
COVID-19
![]() ![]() ![]() ![]() ![]()
CureVac Streamlines European Network for mRNA Product Manufacturing
September 14, 2021
From CureVac
Via AccessWire
![]() From CureVac
Via AccessWire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
South Korea Negotiating With mRNA COVID-19 Vaccine Makers To Produce Up To 1B Doses: Reuters
July 06, 2021
Via Benzinga
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|